Audrey Schmitz
Research Subjects
Audrey Schmitz has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Angelina Orosco
Unit Virology, Immunology and Parasitology in Poultry and Rabbits, Anses, Ploufragan-Plouzané-Niort Laboratory, Ploufragan, France
2 shared publications - Béatrice Grasland
French Agency for Food, Environmental and Occupational Health & Safety (ANSES), Ploufragan-Plouzané-Niort Laboratory, Avian & Rabbit Virology, Immunology & Parasitology Unit, BP53, Ploufragan 22440, France
2 shared publications - Carole Guillemoto
Unit Virology, Immunology and Parasitology in Poultry and Rabbits, Anses, Ploufragan-Plouzané-Niort Laboratory, Ploufragan, France
2 shared publications - Eric Niqueux
Unit Virology, Immunology and Parasitology in Poultry and Rabbits, Anses, Ploufragan-Plouzané-Niort Laboratory, Ploufragan, France
2 shared publications - François-Xavier Briand
French Agency for Food, Environmental and Occupational Health & Safety (ANSES), Ploufragan-Plouzané-Niort Laboratory, Avian & Rabbit Virology, Immunology & Parasitology Unit, BP53, Ploufragan 22440, France
2 shared publications - Rachel Busson
Unit Virology, Immunology and Parasitology in Poultry and Rabbits, Anses, Ploufragan-Plouzané-Niort Laboratory, Ploufragan, France
2 shared publications
Latest Publications
- Open Access
- 3 June 2026
- Published by Springer Nature in Veterinary Research
- Vol. 57 (1)
Pathogenicity and immune response of turkey A(H1N2) influenza virus of swine-origin on turkeys and mice
In 2020, a new swine influenza H1 av N2#E genotype emerged in pig farms in France. Shortly after its emergence in swine, this virus was detected in breeding turkey farms, and was responsible of a zoonotic infection. Phylogenetic analyses previously conducted on viral sequences led to the selection of three viruses: the first strain detected in turkeys, resulting from a recent spillover from swine to turkeys (A); a second virus also detected in turkeys and likely adapted to this species (B); and a swine reference strain (C). In the context of species-barrier crossing, the aim of this study was to characterize in vivo these three viruses in an avian model, the breeding turkey, and in a mammalian model, the mouse. Clinical signs, lesions, viral loads, and immune responses were evaluated. In turkeys inoculated experimentally, all three viruses caused similar very mild clinical signs and no viral shedding. In contrast, in mice, virus A caused marked clinical signs associated with mortality, along with a weak inflammatory response. Conversely, virus C caused few clinical signs but showed a more pronounced inflammatory response. Surprisingly, only two nonsynonymous mutations were present between viruses C and A: K189R in PB1 and E233K in HA. Virus B displayed an intermediate profile. There was no difference in genomic load in the lungs among the three viruses, suggesting that the observed differences in pathogenicity were due to the immune response rather than viral replication.
- 3 June 2026
- Published by Springer Nature in Veterinary Research
- Vol. 57 (1)
Open AccessPathogenicity and immune response of turkey A(H1N2) influenza virus of swine-origin on turkeys and mice
In 2020, a new swine influenza H1 av N2#E genotype emerged in pig farms in France. Shortly after its emergence in swine, this virus was detected in breeding turkey farms, and was responsible of a zoonotic infection. Phylogenetic analyses previously conducted on viral sequences led to the selection of three viruses: the first strain detected in turkeys, resulting from a recent spillover from swine to turkeys (A); a second virus also detected in turkeys and likely adapted to this species (B); and a swine reference strain (C). In the context of species-barrier crossing, the aim of this study was to characterize in vivo these three viruses in an avian model, the breeding turkey, and in a mammalian model, the mouse. Clinical signs, lesions, viral loads, and immune responses were evaluated. In turkeys inoculated experimentally, all three viruses caused similar very mild clinical signs and no viral shedding. In contrast, in mice, virus A caused marked clinical signs associated with mortality, along with a weak inflammatory response. Conversely, virus C caused few clinical signs but showed a more pronounced inflammatory response. Surprisingly, only two nonsynonymous mutations were present between viruses C and A: K189R in PB1 and E233K in HA. Virus B displayed an intermediate profile. There was no difference in genomic load in the lungs among the three viruses, suggesting that the observed differences in pathogenicity were due to the immune response rather than viral replication.
- Open Access
- 1 January 2025
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2025 (1) , 8895883
Highly Pathogenic Clade 2.3.4.4b H5N1 Influenza Virus in Seabirds in France, 2022–2023
In 2022, a very high number of wild bird deaths associated with the detection of highly pathogenic (HP) H5 avian influenza virus (AIV) lineage Gs/GD/96, clade 2.3.4.4b viruses were unusually observed in Europe between May and September, whereas prior to 2022 most of these HP H5 AIVs detected in wild birds in Europe were almost all detected between October and March and few between April and September. In France, wild birds affected by this virus during this unusual period were mainly seabirds, including larids and sulids. Although the abnormal mortalities in larids and sulids were reported simultaneously, sequencing of the complete genomes of the viruses identified in these seabirds showed that sulids are mainly infected with genotype EA‐2020‐C, whereas larids are mainly infected with genotype EA‐2022‐BB. The identification of these two genotypes, therefore, confirmed that there was no direct link between the abnormal mortality observed in sulids and the abnormal mortality observed in larids. These two seabird mortality events can also be distinguished by the evolutionary pattern of the number of detections. Indeed, sulid mortality associated with the EA‐2020‐C genotype was observed in France only between July and September, corresponding to a single epidemic wave, whereas larid mortality associated with the EA‐2022‐BB genotype began in France and Europe in May 2022 and then this genotype continued to spread among larids in France in the form of several successive epidemic waves until at least September 2023.
- 1 January 2025
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2025 (1) , 8895883
Open AccessHighly Pathogenic Clade 2.3.4.4b H5N1 Influenza Virus in Seabirds in France, 2022–2023
In 2022, a very high number of wild bird deaths associated with the detection of highly pathogenic (HP) H5 avian influenza virus (AIV) lineage Gs/GD/96, clade 2.3.4.4b viruses were unusually observed in Europe between May and September, whereas prior to 2022 most of these HP H5 AIVs detected in wild birds in Europe were almost all detected between October and March and few between April and September. In France, wild birds affected by this virus during this unusual period were mainly seabirds, including larids and sulids. Although the abnormal mortalities in larids and sulids were reported simultaneously, sequencing of the complete genomes of the viruses identified in these seabirds showed that sulids are mainly infected with genotype EA‐2020‐C, whereas larids are mainly infected with genotype EA‐2022‐BB. The identification of these two genotypes, therefore, confirmed that there was no direct link between the abnormal mortality observed in sulids and the abnormal mortality observed in larids. These two seabird mortality events can also be distinguished by the evolutionary pattern of the number of detections. Indeed, sulid mortality associated with the EA‐2020‐C genotype was observed in France only between July and September, corresponding to a single epidemic wave, whereas larid mortality associated with the EA‐2022‐BB genotype began in France and Europe in May 2022 and then this genotype continued to spread among larids in France in the form of several successive epidemic waves until at least September 2023.